Guo-Li Ming

Title: Guo-Li Ming: Innovator in Flavivirus Research

Introduction

Guo-Li Ming is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical research, particularly in the treatment and prevention of Flavivirus infections. With a total of three patents to his name, his work has the potential to impact public health significantly.

Latest Patents

Ming's latest patents include innovative methods and compounds for treating Flavivirus infections. One notable patent focuses on emetine compounds for the treatment and prevention of Flavivirus infections, such as dengue virus infections. This invention outlines methods for administering emetine or cephaeline compounds to individuals in need, as well as pharmaceutical compositions and kits designed for this purpose. Another patent addresses the use of various compounds, including niclosamide and emricasan, for the treatment and prevention of Zika virus infections. This patent also details methods for inhibiting Flavivirus infections in vitro and in vivo.

Career Highlights

Throughout his career, Guo-Li Ming has worked with esteemed institutions, including the Florida State University Research Foundation and The Johns Hopkins University. His research has been pivotal in advancing our understanding of Flavivirus infections and developing effective treatments.

Collaborations

Ming has collaborated with notable colleagues, including Hengli Tang and Emily M Lee. These partnerships have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Guo-Li Ming's work in the field of Flavivirus research exemplifies the impact of innovation in medicine. His patents and collaborations highlight his commitment to advancing healthcare solutions.